Participation Statistics

ATTD 2018 aims:

• To bring together the world’s scientific experts to catalyze and advance scientific knowledge about Diabetes, present the most recent research findings, and promote and enhance scientific collaborations around the world.

• To bring together community leaders, scientists, and policy leaders to promote and enhance programmatic collaborations to more effectively address regional, national and local responses to Diabetes around the world and overcome barriers that limit access to prevention, care and services.

Industry Benefits of Supporting ATTD 2018

• Promotes cutting-edge scientific research
• Contributes to the advancement of Advanced Technologies and Treatments for Diabetes on an international level
• Offers a unique opportunity to exchange ideas with renowned professionals from across the world
• Provides an ideal networking forum
• Offers unique exposure to worldwide markets


​​YEAR​CONFERENCE​VENUE​PARTICIPANTS
​2008​1st ATTDPrague, Czech Republic​​742
​2009
​2nd ATTD​Athens, Greece​783
​2010​3rd ATTD​Basel, Switzerland​904
​2011​4th ATTD​London, United Kingdom​1,441
​2012​5th ATTD​Barcelona, Spain​1,700
​2013​6th ATTD​Paris, France​2,117
​2014​7th ATTD​Vienna, Austria​2,0​84
​2015​8th ATTD​Paris, France​2,550
​2016​9th ATTD​Milan, Italy​2,645​
​2017​10th ATTD​Paris, France2,529


Profile of Attendees

The Audience ranges from various fields of expertise such as:
• Researchers and Clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers       as well as general & family medicine practitioners
• Key Opinion Leaders in Diabetes Technology
• MDs and Nurses with interest in Diabetes
• Start Up Companies Looking for Exposure
• Young Generation of MDs

​statistics from Paris 2017